Faithin Omaha eBook Collection

Engineered antibodies currently represent over 30% of biopharmaceuticals in clinical trials and their total worldwide sales continue to increase significantly.

The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the product

If the antibody industry is to achieve its full potential in the next decade, the individual technical potentials must be exploited, the limitations must be add

Integrating advances in molecular biology into bioprocesses presents a continuous challenge to scientists and bioengineers. This series is conceived to help mee

This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is